Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

IOVA

Iovance Biotherapeutics Inc

May 22 • 04:00PM ET

4.11

+0.41 11.08 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: LYEL ALLO AUTL SANA BEAM

| Held by: VTI XBI IWM VB VXF IWN VBR IBB SCHA VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.95	Insider Own	13.12%	Shs Outstand	438.11M	Perf Week	19.13%
Market Cap	1.84B	Forward P/E	-	EPS next Y	-0.31	Insider Trans	0.00%	Shs Float	387.94M	Perf Month	18.10%
Enterprise Value	1.57B	PEG	-	EPS next Q	-0.13	Inst Own	54.47%	Short Float	29.57%	Perf Quarter	42.21%
Income	-353.86M	P/S	6.43	EPS this Y	49.65%	Inst Trans	1.89%	Short Ratio	6.65	Perf Half Y	81.86%
Sales	285.55M	P/B	2.49	EPS next Y	43.59%	ROA	-37.40%	Short Interest	114.71M	Perf YTD	50.55%
Book/sh	1.65	P/C	5.85	EPS next 5Y	-	ROE	-47.51%	52W High	5.63 -27.00%	Perf Year	134.86%
Cash/sh	0.70	P/FCF	-	EPS past 3/5Y	23.93% 10.23%	ROIC	-46.22%	52W Low	1.66 147.59%	Perf 3Y	-48.56%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	25.04%	Volatility	7.87% 7.08%	Perf 5Y	-77.23%
Dividend TTM	-	EV/Sales	5.50	EPS Y/Y TTM	23.00%	Oper. Margin	-125.41%	ATR (14)	0.27	Perf 10Y	-24.73%
Dividend Ex-Date	-	Quick Ratio	3.15	Sales Y/Y TTM	34.26%	Profit Margin	-123.92%	RSI (14)	62.46	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	3.60	EPS Q/Q	47.50%	SMA20	14.07%	Beta	0.69	Target Price	8.80
Payout	-	Debt/Eq	0.07	Sales Q/Q	44.82%	SMA50	13.22%	Rel Volume	1.33	Prev Close	3.70
Employees	975	LT Debt/Eq	0.06	Earnings	May 07 BMO	SMA200	45.66%	Avg Volume	17.25M	Price	4.11
IPO	Sep 01, 2009	Option/Short	Yes / Yes	EPS/Sales Surpr.	-23.70% -8.23%	Trades		Volume	22,944,259	Change	11.08%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)